Progressive new start-up, Phenotypeca Ltd, is delighted to announce that they have expanded their Board of Directors with Simon Chalk being appointed as a Non-Executive Director at the end of December. Simon will play a significant role in defining Phenotypeca’s business growth strategy. Simon joins Phenotypeca...
Intelligent OMICS, Arctoris and Medicines Discovery Catapult test in silico pipeline for identifying new molecules for cancer treatment BioCity client company, Intelligent OMICS, supported by Arctoris and Medicines Discovery Catapult, are applying artificial intelligence to find new disease ‘drivers’ and candidate drugs for lung cancer....
BioCity investee, Rinri Therapeutics, a biotechnology company developing a novel cell-based therapy to restore hearing, today announced the appointment of Dr. Terri Gaskell as its Chief Technology Officer (CTO) and member of the executive team. Dr. Gaskell brings over 20 years of life sciences R&D experience...
Technology that will alert users to the need to replace their face mask has been unveiled by smart packaging company, Insignia Technologies, based at BioCity, Glasgow. Designed to encourage safer mask practice while bringing peace of mind to the public, Insignia’s smart label changes colour to...
Sygnature invests in new capabilities at two of its laboratories. • Automated sample storage for multi-customer, multi-year storage HTS relationships • Flow cytometry at Alderley Park to support ex vivo and in vivo tumour analysis BioCity based Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical...
Medilink Midlands has announced that its newly forged Board of Directors has appointed Dr Darren Clark as Chief Executive Officer and member of the Board of Directors, effective immediately. Darren previously held the position of Chief Executive Officer at Medilink East Midlands. Darren joined Medilink East...
(L-R) Sarah Hardy, Archangels; Carol Thomson, BDD | Photo credit: Jamie Williamson Backing to fund the further expansion of formulation and manufacturing capabilities underpinned by strategic senior appointments Innovative Scottish-based drug delivery company, Bio-Images Drug Delivery Limited (BDD), has positioned itself for rapid growth with a further round of...
On 25 November, five pioneering life science start-ups pitched to a panel of investors as they completed the final part of their journey on the East Midlands AHSN Accelerator, delivered by BioCity. The panel were blown away by the pitches from the entrepreneurs, with wide-ranging innovations...
Macclesfield-based proteomic-data science and diagnostics company, Kinomica, has secured £3.9m in funding for pioneering technology that could prove integral to the development of new drug treatments. KScan™, a next-generation biomarker and molecular diagnostics platform, has been designed to aid the development of kinase inhibitor drugs for...
A University of Dundee spinout company developing treatments for eczema, rheumatoid arthritis and other inflammatory conditions has completed its first round of private investment. BioCity Accelerator alumni, In4Derm Ltd, is an innovative drug discovery company developing the next generation of topical and oral therapies for widespread...